Patent · US Active

Neisseria meningitidis antigens and compositions

US9266929B2 · kind B2 · utility

20Cited by
23References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 1, 2014
Grant dateFeb 23, 2016
Priority date
Expiry dateAug 12, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/825
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides proteins from Neisseria meningitidis, including the amino acid sequences and the corresponding nucleotide sequences. The proteins are predicted to be useful antigens for vaccines and/or diagnostics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.